Yi Xin Selected Research

Yi Xin Research Topics

Disease

14	Neoplasms (Cancer) 12/2021 - 10/2013
12	Lung Injury 01/2022 - 02/2013
10	Inflammation (Inflammations) 03/2022 - 01/2015
6	Tuberculosis (Tuberculoses) 04/2017 - 01/2008
6	Hepatocellular Carcinoma (Hepatoma) 03/2017 - 12/2012
5	COVID-19 01/2022 - 01/2020
4	Edema (Dropsy) 01/2022 - 12/2017
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2021 - 01/2019
4	Acute Lung Injury 01/2021 - 01/2017
4	Pulmonary Atelectasis 01/2018 - 02/2011
4	Carcinogenesis 10/2017 - 10/2016
3	Lung Diseases (Lung Disease) 01/2022 - 05/2012
3	Carcinoma (Carcinomatosis) 12/2021 - 05/2012
3	Ventilator-Induced Lung Injury 01/2021 - 03/2015
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 11/2020 - 12/2014
3	Hypoxia (Hypoxemia) 11/2020 - 01/2017
3	Body Weight (Weight, Body) 01/2020 - 10/2015
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2019 - 11/2014
2	Dysbiosis 03/2022 - 10/2017
2	Emphysema 01/2022 - 01/2012
2	Heart Failure 01/2022 - 10/2011
2	Fatty Liver 01/2021 - 07/2017
2	Obesity 01/2021 - 01/2020
2	Pneumonia (Pneumonitis) 01/2021 - 01/2021
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 07/2020 - 01/2019
2	Diabetes Mellitus 01/2018 - 02/2017
2	Hemorrhage 09/2016 - 01/2015
2	Sepsis (Septicemia) 01/2016 - 03/2015
2	Neoplasm Metastasis (Metastasis) 10/2013 - 12/2012
1	Pulmonary Edema 01/2022
1	Intestinal Diseases (Diseases, Intestinal) 03/2021
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Liver Diseases (Liver Disease) 01/2021
1	Insulin Resistance 01/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 07/2020
1	Infections 07/2019

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 10/2017 - 01/2008
7	Pharmaceutical PreparationsIBA 03/2022 - 01/2008
7	CytokinesIBA 01/2021 - 01/2015
5	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 02/2017
4	Pyruvic Acid (Pyruvate)IBA 11/2020 - 01/2017
3	Hydrochloric Acid (Hydrogen Chloride)FDA Link 10/2021 - 11/2020
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 01/2015
3	Lactic Acid (Lactate)FDA LinkGeneric 11/2020 - 12/2017
3	EnzymesIBA 07/2017 - 01/2008
3	Caspase 3 (Caspase-3)IBA 01/2017 - 10/2016
3	Surface-Active Agents (Surfactants)IBA 02/2015 - 02/2013
2	Pancreatic Elastase (Elastase)IBA 01/2022 - 01/2012
2	PlatinumIBA 12/2021 - 01/2021
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 01/2016
2	Peptides (Polypeptides)IBA 01/2021 - 10/2014
2	Oleic Acid (Oleate)IBA 01/2021 - 01/2021
2	Interleukin-10 (Interleukin 10)IBA 01/2021 - 01/2016
2	salicylhydroxamic acid (SHAM)IBA 11/2020 - 03/2015
2	Sirolimus (Rapamycin)FDA Link 07/2020 - 01/2019
2	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 07/2020 - 01/2019
2	Neuregulin-1 (Neuregulin 1)IBA 07/2020 - 01/2017
2	EndotoxinsIBA 01/2020 - 03/2015
2	Polysaccharides (Glycans)IBA 01/2020 - 12/2017
2	Cisplatin (Platino)FDA LinkGeneric 11/2019 - 01/2019
2	Oxygen (Dioxygen)IBA 01/2019 - 05/2012
2	AcidsIBA 11/2017 - 01/2017
2	HSP27 Heat-Shock ProteinsIBA 10/2017 - 10/2013
2	Dimenhydrinate (DMH)FDA LinkGeneric 10/2016 - 10/2016
2	Amino Acids FDA Link 06/2016 - 08/2012
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2015 - 10/2013
2	Antitubercular AgentsIBA 05/2013 - 01/2008
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	Imatinib Mesylate (Gleevec)FDA Link 01/2022
1	DiureticsIBA 01/2022
1	AminesIBA 01/2021
1	Insulin (Novolin)FDA Link 01/2021
1	CarcinogensIBA 01/2021
1	CarbohydratesIBA 01/2021
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2021
1	Hyaluronic Acid (Hyaluronan)IBA 01/2021
1	Mucin-4IBA 01/2021
1	LY 165163 (PAPP)IBA 01/2021
1	AntigensIBA 01/2021
1	LipidsIBA 01/2021
1	Claudin-4IBA 01/2021
1	B7-H1 AntigenIBA 06/2020
1	Biological ProductsIBA 01/2020
1	LipopolysaccharidesIBA 01/2020

Therapy/Procedure

11	Artificial Respiration (Mechanical Ventilation) 01/2022 - 02/2013
9	Therapeutics 01/2022 - 09/2012
5	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2022 - 02/2011
4	Mechanical Ventilators (Ventilator) 01/2021 - 12/2014
2	Intraperitoneal Injections 01/2021 - 08/2018
2	Renal Dialysis (Hemodialysis) 11/2020 - 01/2020
2	Oral Administration 01/2020 - 07/2019
2	Semiconductors 10/2019 - 08/2018
2	Quantum Dots (Quantum Dot) 10/2019 - 08/2018
2	Ligation 01/2017 - 03/2015
1	Continuous Positive Airway Pressure 01/2022
1	Drug Therapy (Chemotherapy) 01/2021